Sophia Randolph - 30 Jun 2023 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
Chief Medical Officer, Director
Signature
/s/ Peter Garcia, by power of attorney
Issuer symbol
ALXO
Transactions as of
30 Jun 2023
Transactions value $
-$11,781
Form type
4
Filing time
05 Jul 2023, 17:09:35 UTC
Previous filing
13 Jun 2023
Next filing
27 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALXO Common Stock Sale -$11.8K -1.61K -0.57% $7.34 281K 30 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.